Can BSX maintain its earnings momentum into 2025?

**Boston Scientific (BSX) is poised to maintain its earnings momentum into 2025**, based on several key indicators: 1. **Consistent Growth**: BSX has demonstrated a consistent growth trajectory in its net income and diluted EPS. The net income grew by 11.51% to $562 million, and the diluted EPS increased by 11.76% to $0.38. This consistent growth pattern suggests a strong business performance that could continue into the future. |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |BSX|BSX.N|Boston Scientific|2024 Q1|57.00636942675159|4.93E8|169| |BSX|BSX.N|Boston Scientific|2024 Q2|19.25925925925926|3.22E8|169| |BSX|BSX.N|Boston Scientific|2024 Q3|-7.142857142857142|4.68E8|169| |BSX|BSX.N|Boston Scientific|2024 Q4|11.507936507936508|5.62E8|169| |code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code| |---|---|---|---|---|---|---| |BSX|BSX.N|Boston Scientific|2024 Q1|57.14285714285715|0.33|169| |BSX|BSX.N|Boston Scientific|2024 Q2|22.222222222222225|0.22|169| |BSX|BSX.N|Boston Scientific|2024 Q3|-5.8823529411764754|0.32|169| |BSX|BSX.N|Boston Scientific|2024 Q4|11.764705882352935|0.38|169| 2. **Positive Analyst Outlook**: Analysts maintain a strong bullish outlook on BSX, with price targets ranging from $84 to $135 per share. This indicates confidence in the company's future performance, which could translate into continued earnings growth. 3. **Strategic Developments**: BSX has been actively working on strategic catalysts and exploring new market opportunities. These initiatives are likely to contribute to the company's continued growth and profitability. 4. **Financial Health**: The company's robust financial health, as indicated by its credit rating upgrades and strong free cash flow, provides a solid foundation for sustaining its earnings momentum. 5. **Market Position**: BSX's resilience to economic disruptions and strong uptake of its technologies position the company well to capitalize on market opportunities and maintain its earnings growth. In conclusion, the combination of consistent earnings growth, positive analyst sentiment, strategic developments, strong financial health, and a favorable market position suggests that BSX is well-positioned to maintain its earnings momentum into 2025.